Michael R Mattern

Progenra, Inc.

$5,800,503

Attributed

$5,800,503

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY2005–15

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

Funding mix

By agency

NIH$5,800,503 · 11

By mechanism

R44$3,182,461 · 3

R43$2,012,299 · 7

R01$605,743 · 1

Top collaborators

No co-investigators on record.

Most similar at Progenra, Inc.

Same institution · by research overlap

David E Sterner$7,582,782
Benjamin Nicholson$1,181,002

Others in their field

Top investigators on “Ubiquitin”

Rama K Mallampalli · Ohio State University$30,048,445
Ze'ev A Ronai · Mount Sinai School Of Medicine Of Cuny$28,079,720
Alexander J Varshavsky · California Institute Of Technology$27,808,765
Jeffrey Wade Harper · Dana-Farber Cancer Inst$25,447,325
Daniel J Finley · Harvard University (Medical School)$23,295,342
Mark Hochstrasser · University Of Chicago$18,674,039

Research focus

UbiquitinLigaseInhibitor/AntagonistUbiquitin-Protein LigaseMulticatalytic Endopeptidase ComplexPathway InteractionsScreening ProcedureHigh Throughput ScreeningProteasome InhibitorUbiquitinationLeadBaseCellsPharmaceutical PreparationsMalignant NeoplasmsCollectionReporterMultiple MyelomaLibrariesSmall MoleculeSpecificityDrug DiscoveryNumbersEnzymes